Michael Fonstein is President at CLEVELAND BIOLABS INC (CBLI). They have made 3 open-market trades across 1 company since 2009, most recently 2012-06-26.
CIK 0001369806
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5K since 2011, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CBLI | 1,176,465 | — |
Shares reported on the most recent Form 4, priced at the 2012-06-28 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CBLI | SELL | 2012-03-16 | 2012-03-20 | $3.06 | $306K | N/A | N/A | N/A |
| CBLI | BUY | 2011-09-02 | 2011-09-07 | $2.27 | $5K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2010-04-22 | 2010-04-22 | $3.95 | $19K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2010-03-22 | 2010-03-23 | $3.57 | $18K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2010-02-22 | 2010-02-23 | $3.89 | $19K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2010-01-22 | 2010-01-25 | $3.86 | $19K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2009-12-30 | 2010-01-04 | $3.56 | $3K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2009-12-23 | 2009-12-28 | $3.50 | $14K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2009-11-23 | 2009-11-23 | $3.61 | $17K | N/A | N/A | N/A |
| CBLI | SELL | 2009-11-23 | 2009-12-28 | $3.69 | $738 | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2009-10-22 | 2009-10-23 | $4.19 | $21K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2009-09-22 | 2009-09-23 | $3.87 | $19K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2009-08-24 | 2009-08-25 | $4.27 | $21K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.